Giulia Bottai

2.4k total citations · 1 hit paper
27 papers, 1.9k citations indexed

About

Giulia Bottai is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Giulia Bottai has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Giulia Bottai's work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and MicroRNA in disease regulation (5 papers). Giulia Bottai is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and MicroRNA in disease regulation (5 papers). Giulia Bottai collaborates with scholars based in Italy, United States and Hungary. Giulia Bottai's co-authors include Libero Santarpia, Balázs Győrffy, Gyöngyi Munkácsy, Ádám Nagy, András Szabó, András Lánczky, George A. Călin, Laura Paladini, Carlotta Raschioni and Barbara Burwinkel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Giulia Bottai

27 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

2016 585 citations András Lánczky, Ádám Nagy et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulia Bottai Italy	17	1.2k	902	588	299	230	27	1.9k
Jian-Jun Wei United States	32	1.2k 1.0×	789 0.9×	292 0.5×	288 1.0×	284 1.2×	57	2.6k
Bisrat G. Debeb United States	28	1.3k 1.1×	810 0.9×	1.1k 1.9×	310 1.0×	186 0.8×	61	2.3k
Wendy J. Huss United States	22	981 0.8×	497 0.6×	711 1.2×	664 2.2×	202 0.9×	40	1.8k
Cailu Song China	23	1.3k 1.0×	968 1.1×	483 0.8×	253 0.8×	155 0.7×	36	1.8k
Shalom Madar Israel	22	1.0k 0.8×	583 0.6×	736 1.3×	202 0.7×	163 0.7×	27	1.6k
Jessamy Tiffen Australia	21	1.3k 1.0×	393 0.4×	599 1.0×	173 0.6×	388 1.7×	40	1.8k
Ruth Rodríguez‐Barrueco United States	15	1.2k 0.9×	699 0.8×	721 1.2×	288 1.0×	142 0.6×	26	1.8k
Lesley Mathews United States	15	862 0.7×	374 0.4×	604 1.0×	253 0.8×	159 0.7×	21	1.4k
Douglas S. Micalizzi United States	14	1.6k 1.3×	841 0.9×	1.2k 2.0×	293 1.0×	145 0.6×	25	2.4k
Giridhar Mudduluru Germany	22	1.6k 1.3×	1.1k 1.2×	437 0.7×	126 0.4×	327 1.4×	30	2.1k

Countries citing papers authored by Giulia Bottai

Since Specialization

Citations

This map shows the geographic impact of Giulia Bottai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bottai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bottai more than expected).

Fields of papers citing papers by Giulia Bottai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Bottai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bottai. The network helps show where Giulia Bottai may publish in the future.

Co-authorship network of co-authors of Giulia Bottai

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Bottai. A scholar is included among the top collaborators of Giulia Bottai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Bottai. Giulia Bottai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masci, Giovanna, Elisa Agostinetto, Laura Giordano, et al.. (2020). Prognostic factors and outcome of HER2+ breast cancer with CNS metastases. Future Oncology. 16(7). 269–279. 7 indexed citations

Győrffy, Balázs, Lőrinc Sándor Pongor, Giulia Bottai, et al.. (2018). An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes. British Journal of Cancer. 118(8). 1107–1114. 23 indexed citations

Bottai, Giulia, Marta Truffi, Fabio Corsi, & Libero Santarpia. (2017). Progress in nonviral gene therapy for breast cancer and what comes next?. Expert Opinion on Biological Therapy. 17(5). 595–611. 33 indexed citations

Losurdo, Agnese, Giuseppe Gullo, Giovanna Masci, et al.. (2017). Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature. Critical Reviews in Oncology/Hematology. 113. 283–291. 36 indexed citations

Bottai, Giulia, Ahmed Nagy, L. Pusztai, et al.. (2017). Abstract P1-07-06: Immune signatures define and affect prognosis in triple-negative breast cancer subtypes. Cancer Research. 77(4_Supplement). P1–7. 1 indexed citations

Győrffy, Balázs, Giulia Bottai, Ádám Nagy, Lajos Pusztai, & Libero Santarpia. (2017). Immune gene signatures in triple-negative breast cancers characterized by varying levels of chromosomal instability.. Journal of Clinical Oncology. 35(15_suppl). 1096–1096. 3 indexed citations

Santarpia, Libero, Giulia Bottai, Catherine M. Kelly, et al.. (2016). Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer. The Oncologist. 21(9). 1063–1078. 38 indexed citations

Bottai, Giulia, Carlotta Raschioni, Agnese Losurdo, et al.. (2016). An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers. Breast Cancer Research. 18(1). 121–121. 91 indexed citations

Paladini, Laura, Linda Fabris, Giulia Bottai, et al.. (2016). Targeting microRNAs as key modulators of tumor immune response. Journal of Experimental & Clinical Cancer Research. 35(1). 103–103. 153 indexed citations

10.

Lánczky, András, Ádám Nagy, Giulia Bottai, et al.. (2016). miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Research and Treatment. 160(3). 439–446. 585 indexed citations breakdown →

11.

Bottai, Giulia, et al.. (2016). Role of inflammation in obesity-related breast cancer. Current Opinion in Pharmacology. 31. 114–122. 43 indexed citations

12.

Bottai, Giulia, Carlotta Raschioni, Agnese Losurdo, et al.. (2016). Abstract P4-04-06: Immune balance between tumor-infiltrating lymphocytes and tumor-associated macrophages impacts the outcome of triple negative breast cancer patients. Cancer Research. 76(4_Supplement). P4–4. 2 indexed citations

13.

Bottai, Giulia, Carlotta Raschioni, Borbála Székely, et al.. (2016). AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients. npj Breast Cancer. 2(1). 16033–16033. 46 indexed citations

14.

Győrffy, Balázs, Giulia Bottai, Thomas Fleischer, et al.. (2015). Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes. International Journal of Cancer. 138(1). 87–97. 128 indexed citations

15.

Sahlberg, Kristine Kleivi, Giulia Bottai, Bjørn Naume, et al.. (2014). A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients. Clinical Cancer Research. 21(5). 1207–1214. 186 indexed citations

16.

Győrffy, Balázs, Giulia Bottai, Jacqueline Lehmann‐Che, et al.. (2014). TP53 mutation‐correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53‐mutated breast cancers. Molecular Oncology. 8(3). 508–519. 60 indexed citations

17.

Bottai, Giulia, Barbara Pasculli, George A. Călin, & Libero Santarpia. (2014). Targeting the microRNA-regulating DNA damage/repair pathways in cancer. Expert Opinion on Biological Therapy. 14(11). 1667–1683. 36 indexed citations

18.

Bottai, Giulia, Rosa Mancina, Monica Muratori, Paola Di Gennaro, & Torello Lotti. (2012). 17β‐estradiol protects human skin fibroblasts and keratinocytes against oxidative damage. Journal of the European Academy of Dermatology and Venereology. 27(10). 1236–1243. 32 indexed citations

19.

Santarpia, Libero, Yuan Qi, Katherine Stemke‐Hale, et al.. (2012). Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers. Breast Cancer Research and Treatment. 134(1). 333–343. 94 indexed citations

20.

Modesti, Pietro Amedeo, Gian Gastone Neri Serneri, Tania Gamberi, et al.. (2008). Impaired angiotensin II–extracellular signal-regulated kinase signaling in failing human ventricular myocytes. Journal of Hypertension. 26(10). 2030–2039. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact